IL6 and neoplasm: According to our previously stated hypothesis, radiotherapy-induced inflammation would be particularly harmful for Any C-carriers with ER-negative tumours, as this inflammation represents an additional inflammatory stimulus that induces Any C-carriers to release large amounts of systemic IL-6, explaining the impaired prognosis among those patients.